This is supported by other studies, which have also shown that higher expression of SLC7A11, GPX4 and LPCAT3 is associated with a worse prognosis in AML, while overexpression of TFRC, which encodes the transferrin receptor, was found to protect cells against ferroptosis [113,114]. This evidence concerns the gene TFRC and acute myeloid leukemia.